News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Reitan Colleen F
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 15,151 shares
@ $0 |
|
| 05/19/2023 |
4
| Reitan Colleen F (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 3,454 options to buy
@ $189.87, valued at
$655.8k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2021 |
4
| Reitan Colleen F (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 4,032 options to buy
@ $171.95, valued at
$693.3k
|
|
| 06/04/2021 |
4
| Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 12,848 shares
@ $0 |
|
| 12/07/2020 |
4
| Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 15,889 shares
@ $0 |
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2019 |
4
| Reitan Colleen F (Director) has filed a Form 4 on MYRIAD GENETICS INC|
Txns:
| Granted 11,687 shares
@ $0 |
|
| 07/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2018 |
4
| Reitan Colleen F (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 18,000 options to buy
@ $100.65, valued at
$1.8M
|
|
|
|